Señal de la máquina
Grupo activo de ventas — 3 iniciados distintos, $4.7M, la ventana termina el Oct 1, 2026.
Cifras calculadas a partir de notificaciones regulatorias oficiales — .
Analistasobjetivo 367.67 USD (+7%) · consenso 4.21/5 · 10 compra · 4 mantener · 0 venta
Propiedadiniciados 4.3% · instituciones 99.43% · posiciones cortas 2.3% del flotante
En USD · a Oct 19, 2026
Pregúntale a la máquina
Busca y compara operaciones de iniciados, sociedades y sus estadísticas en lenguaje natural. Tu pregunta se convierte en una consulta sobre los datos disponibles, no en una conversación ni en asesoramiento de inversión.
Solo datos de Cencora, Inc.. Sin búsqueda web. Se excluyen las estadísticas globales de cada iniciado.
Una búsqueda ejecutada consume un crédito, incluso sin resultados. Los errores y las preguntas no compatibles no consumen créditos.
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
Fuente de información de mercado · Oct 19, 2026
Periodos registrados en las fuentes consultadas. No certifican las fechas legales de los cambios de nombre.
Identidad según la SEC · Oct 19, 2026
Cronología en el mercado · historial completo
18 compras476 ventas— precio de cierrebarra = volumen usd, escala √haz clic en un periodo para filtrar la tabla
| Iniciado | Tipo | Valor · USD | Señales | Detalle | |
|---|---|---|---|---|---|
| Krikorian Lazarus | Venta | $298.9K | SEC |
| SANCHEZ ROBERT E | Asignación | n/d (La notificación no indica precio) | SEC |
| GREENBERG LON Rhistorial | Venta | $411.3K | SEC |
| Krikorian Lazarus | Venta | $321.1K | SEC |
| Campbell Elizabeth S | Venta | $3.7M | Tamaño inusual | SEC |
| NALLY DENNIS M | Asignación | $35.2K | SEC |
| Cooper Ellen | Asignación | $30.2K | SEC |
| Tyler Lauren M | Asignación | $30.2K | SEC |
| COLLIS STEVEN H | EjercicioD (derivado) | n/d (Operación sin contrapartida en efectivo: la notificación indica precio cero (concesión, donación, ejercicio)) | SEC |
| COLLIS STEVEN H | Ejercicio | $814K | SEC |
| COLLIS STEVEN H | Venta | $2M | SEC |
| Walgreens Boots Alliance Holdings LLC | Venta | $250M | SEC |
| Walgreens Boots Alliance Holdings LLC | OtroD (derivado) | n/d (La notificación no indica precio) | SEC |
| Walgreens Boots Alliance Holdings LLC | OtroD (derivado) | n/d (La notificación no indica precio) | SEC |
| Walgreens Boots Alliance Holdings LLC | OtroD (derivado) | n/d (La notificación no indica precio) | SEC |
| Walgreens Boots Alliance Holdings LLC | OtroD (derivado) | n/d (La notificación no indica precio) | SEC |
| Walgreens Boots Alliance Holdings LLC | OtroD (derivado) | n/d (La notificación no indica precio) | SEC |
| Walgreens Boots Alliance Holdings LLC | OtroD (derivado) | n/d (La notificación no indica precio) | SEC |
| Walgreens Boots Alliance Holdings LLC | OtroD (derivado) | n/d (La notificación no indica precio) | SEC |
| Walgreens Boots Alliance Holdings LLC | OtroD (derivado) | n/d (La notificación no indica precio) | SEC |
| Walgreens Boots Alliance Holdings LLC | OtroD (derivado) | n/d (La notificación no indica precio) | SEC |
| Walgreens Boots Alliance Holdings LLC | OtroD (derivado) | n/d (La notificación no indica precio) | SEC |
| Walgreens Boots Alliance Holdings LLC | OtroD (derivado) | n/d (La notificación no indica precio) | SEC |
| Walgreens Boots Alliance Holdings LLC | OtroD (derivado) | n/d (La notificación no indica precio) | SEC |
| NALLY DENNIS M | Asignación | $31.4K | SEC |